Olimel N7e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

Olimel N7e provides amino acid supplementation that supports several metabolic pathways.

• Protein‑energy malnutrition: helps restore nitrogen balance and lean body mass.
• Post‑surgical recovery: aids tissue repair and wound healing.
• Chronic kidney disease (conservative management): contributes to maintaining plasma amino acid levels.
• Oncology supportive care: assists in counteracting treatment‑related catabolism.
• Critical illness: supports overall nutritional status during intensive care.

• The amino acids in Olimel N7e are absorbed in the gastrointestinal tract and enter systemic circulation, where they serve as substrates for protein synthesis, act as precursors for neurotransmitters and metabolic intermediates, and participate in nitrogen transport. By replenishing depleted amino acid pools, the formulation helps maintain cellular function and supports anabolic processes essential for recovery and growth.

Adverse reactions to amino‑acid mixtures are generally mild and related to gastrointestinal tolerance.

Common Side Effects

• Nausea: mild, transient upset stomach.
• Diarrhea: loose stools, usually self‑limiting.
• Abdominal discomfort: cramping or bloating.
• Metallic taste: transient alteration in mouthfeel.
• Headache: mild, occasional.

Serious or Rare Side Effects

• Allergic reaction: rash, pruritus, or angio‑edema.
• Hyperammonemia: elevated blood ammonia in susceptible patients.
• Metabolic imbalance: disturbances in electrolytes or acid‑base status.
• Hepatic dysfunction: abnormal liver enzymes in rare cases.
• Severe gastrointestinal intolerance: persistent vomiting or severe diarrhea.

When prescribing Olimel N7e, clinicians should consider patient‑specific factors and monitor for potential issues.

• Renal impairment: adjust monitoring of plasma amino acids.
• Hepatic disease: watch for signs of hyperammonemia.
• Pregnancy and lactation: evaluate risk‑benefit before use.
• Concomitant medications: assess for interactions affecting amino‑acid metabolism.
• Pediatric use: dose and safety data are limited; use with caution.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Amino‑acid mixtures can influence the absorption or metabolism of certain drugs.

Major Interactions (Avoid)

• Levodopa: reduced absorption may diminish therapeutic effect.
• Anticonvulsants (e.g., phenobarbital): increased catabolism of amino acids.

Moderate Interactions (Monitor Closely)

• Thyroid hormones: potential alteration in protein binding.
• Antibiotics (tetracyclines, quinolones): chelation may reduce oral bioavailability.
• Iron supplements: concurrent intake can impair absorption of both agents.
• Diuretics: may affect electrolyte balance when combined with high amino‑acid loads.
• Statins: theoretical risk of altered hepatic metabolism.